269 related articles for article (PubMed ID: 20298292)
21. Yellow nail syndrome with chylothorax after coronary artery bypass grafting.
Waliany S; Chandler J; Hovsepian D; Boyd J; Lui N
J Cardiothorac Surg; 2018 Sep; 13(1):93. PubMed ID: 30201014
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous neonatal chylothorax treated with octreotide.
Siu SL; Lam DS
J Paediatr Child Health; 2006; 42(1-2):65-7. PubMed ID: 16487393
[TBL] [Abstract][Full Text] [Related]
23. Yellow Nail Syndrome Presenting With a Pericardial Effusion: A Case Report and Review of the Literature.
Soong LC; Haber RM
J Cutan Med Surg; 2018; 22(2):190-193. PubMed ID: 29067826
[TBL] [Abstract][Full Text] [Related]
24. [Current alternative in the pharmacotherapy of acromegaly: the long-acting somatostatin analogue octreotide].
Laczi F; Magony S; Julesz J
Orv Hetil; 2002 May; 143(19 Suppl):1062-6. PubMed ID: 12063861
[TBL] [Abstract][Full Text] [Related]
25. "Yellow nail syndrome" and rheumatoid arthritis.
Ichikawa Y; Shimizu H; Arimori S
Tokai J Exp Clin Med; 1991 Dec; 16(5-6):203-9. PubMed ID: 1820660
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of patients with yellow nail syndrome and pleural effusion.
Valdés L; Huggins JT; Gude F; Ferreiro L; Alvarez-Dobaño JM; Golpe A; Toubes ME; González-Barcala FJ; José ES; Sahn SA
Respirology; 2014 Oct; 19(7):985-92. PubMed ID: 25123563
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of clarithromycin in patients with yellow nail syndrome.
Matsubayashi S; Suzuki M; Suzuki T; Shiozawa A; Kobayashi K; Ishii S; Iikura M; Izumi S; Kudo K; Sugiyama H
BMC Pulm Med; 2018 Aug; 18(1):138. PubMed ID: 30111321
[TBL] [Abstract][Full Text] [Related]
28. Octreotide therapy in dumping syndrome: Analysis of long-term results.
Didden P; Penning C; Masclee AA
Aliment Pharmacol Ther; 2006 Nov; 24(9):1367-75. PubMed ID: 17059518
[TBL] [Abstract][Full Text] [Related]
29. The yellow nail syndrome. Light and electron microscopic aspects of the pleura.
Solal-Céligny P; Cormier Y; Fournier M
Arch Pathol Lab Med; 1983 Apr; 107(4):183-5. PubMed ID: 6687537
[TBL] [Abstract][Full Text] [Related]
30. A case of the yellow nail syndrome associated with massive chylous ascites, pleural and pericardial effusions.
Malek NP; Ocran K; Tietge UJ; Maschek H; Gratz KF; Trautwein C; Wagner S; Manns MP
Z Gastroenterol; 1996 Nov; 34(11):763-6. PubMed ID: 8956479
[TBL] [Abstract][Full Text] [Related]
31. [Experience in treating acromegalic patients with long-acting octreotide].
Szücs N; Mészáros J; Czirják S; Mondok A; Varga I; Gláz E
Orv Hetil; 2002 May; 143(19 Suppl):1066-70. PubMed ID: 12063862
[TBL] [Abstract][Full Text] [Related]
32. [Yellow nail syndrome].
Gunnarsson O; Bjornsson E; Björnsdóttir US; Gudbjartsson T
Laeknabladid; 2007 Nov; 93(11):751-3. PubMed ID: 17984553
[TBL] [Abstract][Full Text] [Related]
33. Octreotide in the treatment of congenital chylothorax.
Rasiah SV; Oei J; Lui K
J Paediatr Child Health; 2004; 40(9-10):585-8. PubMed ID: 15367160
[TBL] [Abstract][Full Text] [Related]
34. [Yellow nail syndrome].
Hausmann M; Keller R
Pneumologie; 1994 Jan; 48(1):30-3. PubMed ID: 8153117
[TBL] [Abstract][Full Text] [Related]
35. Yellow nail syndrome.
Elmariah SB; Ubriani RR; Kovich O
Dermatol Online J; 2008 Oct; 14(10):17. PubMed ID: 19061616
[TBL] [Abstract][Full Text] [Related]
36. Coexistent yellow nail syndrome and selective antibody deficiency.
Bokszczanin A; Levinson AI
Ann Allergy Asthma Immunol; 2003 Nov; 91(5):496-500. PubMed ID: 14692436
[TBL] [Abstract][Full Text] [Related]
37. Yellow nail syndrome resulting from cardiac mitral valve replacement.
Sarmast H; Takriti A
J Cardiothorac Surg; 2019 Apr; 14(1):72. PubMed ID: 30971303
[TBL] [Abstract][Full Text] [Related]
38. Yellow nail syndrome: a rarity in Indians?
Nair VK; Sukumaran P
Indian J Chest Dis Allied Sci; 1996; 38(1):39-43. PubMed ID: 16892747
[TBL] [Abstract][Full Text] [Related]
39. [Upper respiratory tract manifestations in yellow nail syndrome].
Primov-Fever A; Kronenberg J; Talmi YP
Harefuah; 2002 Oct; 141(10):871-2, 931. PubMed ID: 12420589
[TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction.
Shima Y; Ohtsu A; Shirao K; Sasaki Y
Jpn J Clin Oncol; 2008 May; 38(5):354-9. PubMed ID: 18490369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
